Diagnosed with type 1 diabetes (T1D) at age 11, Jennifer McVean, MD, had not heard of TrialNet until she began working as a pediatric endocrinologist. Now, as part of the pediatric endocrinology team at University of Minnesota, Dr. McVean is a TrialNet advocate heavily involved in spreading the word about screening and studies.

A newly launched prevention study will test the drug hydroxychloroquine (HCQ) to see if it can delay or prevent early stage T1D (stage 1) from progressing to abnormal glucose tolerance (stage 2) and ultimately prevent clinical diagnosis (st

TrialNet screening is free, quick, and now more convenient than ever. Our new in-home test kits provide everything you need to collect your or your family member’s blood sample in the comfort of your home.